| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |